Purpose of Review Compared to adult-onset type 2 diabetes (T2D), youth with T2D have a more aggressive phenotype with greater insulin resistance (IR), more rapid β cell decline, and higher prevalence of diabetic kidney disease (DKD). Recent Findings Hyperfiltration is common in youth with T2D and predicts progressive DKD. Hyperfiltration is a consequence of early changes in intrarenal hemodynamic function, including increased renal plasma flow (RPF) and glomerular pressure. Girls with T2D are disproportionally affected by DKD, with a 3-fold greater risk of developing hyperfiltration over 5 years compared to boys. Despite the high prevalence and gravity of DKD in youth-onset T2D, widely effective therapeutic options are lacking. Summary In this review, we focus on pathophysiology underlying early DKD in T2D and sex differences and summarize promising novel medical therapies and bariatric surgery.
Introduction
In the USA, almost half of the patients with end-stage renal disease (ESRD) have diabetic kidney disease, and over 80% of these have type 2 diabetes (T2D) [1••] . T2D in youth has a female predominance and is increasing in prevalence [1••, 2, 3] . Further, girls with T2D are also disproportionally impacted by diabetic kidney disease (DKD), with a 3-fold greater risk of developing DKD [4••] . Elevated albumin excretion is present in up to one third of adolescents with T2D [5] . Since elevated albumin excretion, the traditional measure of renal injury in T2D, does not reliably reflect progressive DKD and commonly regresses to normal albumin excretion [6] , it is important to directly examine early changes in renal function that are associated with future DKD risk, such as hyperfiltration. Hyperfiltration impacts between 24 and 50% of youth with T2D as assessed by estimated GFR (eGFR) using creatinine and cystatin-C equations [4••, 5] , which is likely an underestimation of GFR, especially with increasing GFR values in the hyperfiltration range [7] .
Hyperfiltration is a consequence of early changes in intrarenal hemodynamic function, including increased renal plasma flow (RPF) and glomerular pressure [8, 9•, 10] . Our preliminary data have suggested that insulin resistance, rather than traditional risk factors, including blood pressure, glycemic control, and dyslipidemia, is the strongest determinant for hyperfiltration in youth-onset T2D [5] . The pathophysiology underlying the early changes in intrarenal hemodynamic function, as well as the relationship between insulin resistance, the role of hyperfiltration on GFR decline, and renal injury, remains unclear. Furthermore, it is unknown why girls have a greater propensity for hyperfiltration compared to boys with T2D, which may contribute to their future risk of clinical DKD.
Despite the high prevalence and gravity of DKD in youthonset T2D, the availability of effective therapeutic options is lacking. Bariatric surgery is an emerging approach that offers remission of T2D in the vast majority of adults, along with improvement in weight, as well as changes in IR and DKD risk markers that may be weight-independent [11, 12••] . While there are no studies to date investigating the effects of bariatric surgery or SGTL2 inhibition on intrarenal hemodynamic function and hyperfiltration in youth-onset T2D, bariatric surgery does reduce hyperfiltration in obese adults [13] . On the medical side, SGLT2 inhibition attenuates hyperfiltration in adults with T1D [10] and is associated with renal and cardiovascular protective effects in adults with T2D at high cardiovascular risk [14••, 15, 16] . In addition, SGLT2 inhibition improves insulin sensitivity in adults [17] . Among newer antihyperglycemic agents, attenuation of hyperfiltration and improvement in intrarenal hemodynamic function appears to be unique to SGLT2 inhibitors, and has not been observed with glucagon-like peptide (GLP)1 receptor agonists or dipeptidyl peptidase-4 inhibitors in adults with T2D [18] [19] [20] . A better understanding of the mechanisms contributing to hyperfiltration and its relationship with IR and progression of DKD in youth-onset T2D is critical to inform medical decision-making and improve the renal health and mortality of children with T2D. In this review, we focus on the potential pathophysiology underlying early DKD in T2D and summarize risk factors and potential novel therapeutic approaches for this condition.
The Risk of DKD in Youth-Onset T2D
Youth with T2D are at an increased risk for DKD, with up to 45% of these patients subsequently progressing to ESRD. This risk is significantly higher compared to youth with type 1 diabetes and compared to adults with adult-onset T2D [21] [22] [23] . We previously reported a prevalence of 24% for hyperfiltration and 35% for elevated albumin excretion in a small cohort of youth with T2D (mean age of 15 ± 2 years) [2] . In a separate analysis of longitudinal data from the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) study, the prevalence of increased albumin excretion rose from 6.3% of participants at baseline to 16.6% at 3.9 years follow-up [3] and 18.0% at 5 years follow-up [4••] . In the SEARCH study, the age-adjusted prevalence of DKD in youth with T2D was 20%, which was significantly greater than DKD in youth with T1D (6%, p < 0.001) [ 
Pathophysiology of Hyperfiltration
The kidneys are metabolically active and have a high energy requirement to sustain filtration, intrarenal hemodynamic function, and tubular reabsorption [25] . Diabetes is associated with an increase in energy and hence O 2 consumption, in part due to the greater filtered load of glucose and the associated rise in GFR [26, 27] into the hyperfiltration range [28] . However, in T2D, emerging animal data suggest that the kidneys are not able to sufficiently compensate for the increased O 2 consumption due to the effects of diabetes on O 2 utilization, leading to a relative state of hypoxia and ischemia [29] [30] [31] . In addition to increased O 2 consumption, renal hypoxia may be worsened by insulin resistance (IR)-associated AMP-activated protein kinase inhibition, resulting in ATP depletion [25, [29] [30] [31] [32] [33] [34] . Hyperglycemia and IR are also associated with mitochondrial dysfunction [35] , leading to impaired electrolyte transport [28] . Accordingly, changes in fuel substrate utilization and energy efficiency, in conjunction with increase metabolic demands from hyperfiltration in the setting of T2D, appear to contribute to a state of renal hypoxia and DKD progression ( Fig. 1) .
This paradigm is supported by the observation that IR and hyperfiltration are strongly correlated in youth with T2D who participated in the RESISTANT and TODAY studies [4••, 5] . In the RESISTANT cohort, adolescents with T2D exhibited significantly lower peripheral insulin sensitivity measured by a hyperinsulinemic-euglycemic clamp, and higher eGFR compared to obese or lean controls [5] . Stratifying eGFR into tertiles, adolescents with T2D in the highest tertile of eGFR were more IR than those in the mid and low tertiles, even after adjusting for age, sex, pubertal stage, BMI, and HbA1c [5] . Furthermore, IR, but not HbA1c, LDL-C, or BP, was also inversely associated with eGFR after adjusting for sex and pubertal stage [5] . In the TODAY study, there was an annual increase in eGFR, and a decrease in eIS over 5 years, and IR independently conferred a 2.1-fold increased risk of hyperfiltration, even after adjusting for other established risk factors (HR: 2.15, p = 0.01) [4••] . Importantly, IR, rather than traditional risk factors, was the strongest determinant of renal health [4••, 5] .
Sex-Related Differences and Early DKD
In TODAY, girls with T2D had higher estimated GFR levels at baseline compared to boys (123 ± 19 vs. 108 ± 17 ml/min/ 1.73m 2 , p < 0.0001 [n = 532]), and a 3-fold greater risk of developing hyperfiltration over 5 years, even after adjustment for age, ethnicity, treatment group, BMI, HbA1c, hypertension, loss of glycemic control, and estimated insulin sensitivity (Fig. 2) [4••] . These sex-related findings do not appear to be unique to T2D. In an analysis in youth with T1D, we found that adolescent girls with T1D had a 4-fold increase in the prevalence of hyperfiltration compared to boys of similar age and glycemic control, with a similar difference observed for elevated albumin excretion [36] . Despite these observations from observational studies, the mechanisms responsible for the increased risk of hyperfiltration in girls vs. boys remain poorly understood. In our previous work, we have reported distinct intrarenal hemodynamic differences in women vs. men with T1D, whereby hyperfiltration in women is characterized by an increase in efferent arteriolar resistance [37] (Fig. 3) . While there are no such data in youth with DKD, we theorize that this sexspecific intrarenal hemodynamic dysfunction may explain the greater prevalence and incidence of hyperfiltration observed in adolescent girls with T1D and T2D, possibly due to sex-related effects on the renin-angiotensin-aldosterone system (RAAS) or on nitric oxide bioactivity, leading to efferent arteriolar vasoconstriction [38] [39] [40] [41] . For example, experimental models suggest that estradiol may upregulate expression of renal angiotensin II receptor type 1 (AT1R) in the setting of high angiotensin II concentrations [42] . Hyperglycemia is associated with RAAS activation and higher concentrations of angiotensin II. Therefore, it is plausible that the greater efferent arteriolar resistance observed in women with T1D may be ascribed to upregulation of AT1R in the setting of RAAS activation. Dedicated renal physiology studies are therefore now needed in youth with T1D and T2D to elucidate sex differences in intrarenal hemodynamic dysfunction.
Potential Novel Therapies for Hyperfiltration

Metabolic Surgery
Bariatric surgery is a new approach that offers remission of T2D in the vast majority of adults, along with improvement in weight, as well as changes in IR and DKD risk markers that may be weight-independent [11, 12••] . In the Teen-LABS study, bariatric surgery in nondiabetic youth resulted in reduction in weight (BMI decline of 38%), improvement in IR at 3 months, and normalization (increased by 300%) by 1 year after surgery [11] . In the small subset of youth with T2D studied, remission of T2D was seen in 95% of participants at 3 years of follow-up [12••] . In a parallel analysis in youthonset T2D who underwent bariatric surgery (Teen-LABS) vs. medical management (TODAY), the proportion of participants in Teen-LABS with elevated albumin excretion decreased from 26 to 5% over 2 years. Conversely, the prevalence of elevated albumin excretion did not change over time in TODAY [43] . No data exist on the effect of bariatric surgery on hyperfiltration, intrarenal hemodynamic function, or renal O 2 in youth-onset T2D (Fig. 4) . A better understanding of the effects of bariatric surgery on intrarenal hemodynamic function and renal O 2 is critical to help define mechanisms of Supraphysiologic GFR (hyperfiltration) leads to vascular changes, inflammation, fibrosis, and nephron loss over time Fig. 2 Greater risk of hyperfiltration in girls vs. boys with T2D. Adjusted for estimated insulin sensitivity, age, ethnicity, treatment group, BMI, HbA1c, hypertension, and loss of glycemic control (primary outcome) surgical benefits and identify potential novel future nonsurgical approaches to DKD.
Antihyperglycemic and Natriuretic Agents
Experimental models of diabetes have suggested that the process of early DKD starts with hyperfiltration and glucosuria, which enhanced sodium/glucose reabsorption through SGLT2. The resultant increased proximal tubular intracellular sodium concentration and activation of basolateral Na + /K + ATPase lead to net increased renal O 2 consumption compared to nondiabetic models [25, [29] [30] [31] . With increased renal O 2 consumption in DKD, energy-efficient fuel is required to meet the increased demand and prevent renal hypoxia. Emerging animal data show that organs prone to complications are unable to compensate for the effects of diabetes on fuel generation [29] [30] [31] .
SGLT2 inhibitors reduce blood pressure, weight, and hyperglycemia in adults with T2D. Furthermore, in the EMPA-REG OUTCOME trial, a 38% reduction in cardiovascular death and a 39% reduction in incident or worsening nephropathy have been demonstrated with the selective SGLT2 inhibitor, empagliflozin, in adults with T2D [15, 44••] . The CANVAS study reported similar results with the selective SGLT2 inhibitor, canagliflozin, in adults with T2D [14••] . It appears that SGLT2 inhibitors reduce hyperfiltration in adults with T1D by increasing natriuresis, resulting in afferent vasoconstriction and declines in intraglomerular hypertension [10] . In adults with T2D, the reduction in intraglomerular hypertension was reflected by a mean reduction in eGFR of 2-4 ml/ min/1.73m 2 after treatment initiation, followed by a stabilization of eGFR decline compared to placebo during long-term treatment [15] . Therefore, the initial decline in eGFR likely reflects attenuation of single-nephron hyperfiltration, which is associated with subsequent long-term renal function preservation [45] . It is not known whether these renal hemodynamic effects occur in youth-onset T2D, as there are no published studies to date examining the effect of SGLT2 inhibitors on intrarenal hemodynamic function in this patient population.
GLP-1 receptor agonists also affect proximal tubular reabsorption resulting in increased natriuresis, at least initially, [46] and have shown to reduce incident or worsening nephropathy in adults with T2D in the LEADER [47] and SUSTAIN6 trials [48] . However, the beneficial intrarenal hemodynamic function responses observed with SGLT2 inhibitors have not been demonstrated with GLP-1 agonists [49] . Fig. 4 Proposed mechanism of bariatric surgery on hyperfiltration. Youth-onset T2D is characterized by IR, central obesity, and hyperfiltration, due to afferent arteriolar vasodilation (a) with increased renal blood flow (RBF) and glomerular pressure. We theorize that the improvement in IR and central adiposity and remission of T2D will normalize the afferent arteriolar tone (b) and attenuate hyperfiltration, with resultant normalization of the O 2 consumption/utilization mismatch Fig. 3 Greater efferent arteriolar resistance in women vs. men, with resultant increased glomerular pressure and GFR
The reduction of DKD with GLP-1 receptor agonists may instead relate to nonhemodynamic, anti-inflammatory effects. Similarly, dipeptidyl peptidase-4 (DPP-4) inhibitors do not appear to affect intrarenal hemodynamic function [49] . Longer-term cardio-renal protection with DPP4 inhibitors is b e i n g e x a m i n e d i n t h e o n g o i n g C A R M E L I N A (NCT01897532) and CAROLINA (NCT01243424) trials in adults with T2D.
Current Unmet Needs: DKD and Youth Onset T2D
To date, there are no DKD-specific clinical trials in youthonset T2D. Some of the reasons include (1) youth-onset T2D remains a relatively rare disease (albeit increasing in prevalence), (2) youth-onset T2D patients represent a cohort that is difficult to recruit for research, (3) the need for long follow-up to capture hard end-points (ESRD and dialysis) is challenging due to the long natural history of the disease, and (4) prohibitive costs to perform large clinical trials with long follow-up. Accordingly, there is an impetus for smaller, costeffective mechanistic trials with gold-standard methods to quantify early changes in renal function, including trials with measures of intrarenal hemodynamic function, which have until now focused primarily on adults with T1D and adultonset T2D [50•, 51, 52•] . These studies have established that intrarenal hemodynamic dysfunction is common [8, 18, 51, 53] and may be reversed with therapeutic agents early in the course of the disease [10, 49] . Yet, no such data are available for youth-onset T2D, a disease that carries a significantly high risk of progressive DKD [21-23, 24••, 54-60] . Knowledge gaps and specific research priorities to prevent or delay the development of DKD in youth with T2D are listed in Table 1 .
Conclusion
With the current pediatric obesity epidemic and the rising incidence of youth-onset T2D [60, 61] , a greater understanding around the pathophysiology underlying the initiation and progression of hyperfiltration and its relationship with progressive DKD is urgently needed. Carefully designed mechanistic human studies are required to advance our understanding of the intrarenal hemodynamic dysfunction of youth-onset T2D, the role of renal oxygenation and metabolism, and the impact of metabolic surgery and novel antihyperglycemic therapies on these parameters. Such research endeavors have the potential to improve the renal health and mortality of obese children worldwide.
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